Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Alnylam Wheels, Deals, and Gets $700M Investment From Genzyme 01/13/14 Boston
Zymeworks Nabs $15M, Adds Lilly Partnership, in Antibody Drug Quest 01/09/14 Seattle
Tillman Gerngross, the Scientist Turned Scientific Businessman 01/09/14 Boston
Investors Sink Tesaro Shares on Phase 3 Misses For Cancer Drug 12/23/13 Boston
What Was Hyped, and What Fell Out of Favor, This Year in Biotech 12/16/13 National
12 Things the Pharma Industry Can Do to Rebuild Real Public Trust 12/09/13 National
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
3 Life Sciences Companies That Are Built to Last 12/02/13 National
Armo BioSciences Joins the Cancer Immunotherapy Party With $20M 11/25/13 San Francisco
Flagship Takes a Stab at Microbiome Therapy With Seres Health 11/21/13 Boston
Dendreon Cuts 150 Jobs, As Prostate Cancer Drug Sales Decline 11/12/13 Seattle
Zalicus Pain Drug Flops in Two Key Clinical Studies 11/11/13 Boston
Immune Design Grabs $32.5M, Cashing in on Cancer Immunotherapy Rush 10/30/13 Seattle
Pharma Showing Interest in Open Systems for Drug Discovery 10/23/13 National
Regeneron, Sanofi Pass First Key Test With Cholesterol-Lowering Drug 10/16/13 New York
East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More 10/04/13 Boston
Merck, J&J Back Stanford Student Incubator as Farm Team 10/03/13 San Francisco
The Pharma Bureaucracy Index: Who’s Nimble, and Who’s Sloooowww? 09/30/13 National
Are Some Degrees Better than Others for Big Pharma Leaders? 09/09/13 Seattle
East Coast Life Sciences Roundup: Syndax, Enteris, Invivo, & More 08/30/13 Boston
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug 08/27/13 Boston
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals 08/20/13 Boston
Six Reasons Why Giving Scientists Big Bonuses Won’t Fix Pharma R&D 08/12/13 National
Pharma Fails Credibility Test, Misses Opportunity, on Transparency 07/29/13 National
Celgene Nabs Option to Buy Acetylon for More Than $1.7B 07/29/13 Boston
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals 07/26/13 Boston
Tillman Gerngross’ Plan to Revamp Tech Transfer at Dartmouth 07/24/13 Boston
Array Shares Climb After Asthma Drug Shows Positive Phase 2 Results 07/23/13 Boulder/Denver
Page 2 of 16 « previous page · next page »